Amgen Inc Patent Portfolio Statistics
Profile Summary
This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.
How does the overall patent portfolio of Amgen Inc. look like?
| Assignee | Art Units | |
| Total Applications: | 2,149 | 1,845,628 |
| Granted Patents: | 1,114 | 982,007 |
| Grant Index | 72.01% ↑ | 67.79% |
| Abandoned/Rejected Applications: | 433 (27.99%) | 466,643 (32.21%) |
| In-Process Applications: | 596 | 396,978 |
| Average Grant Time: | 3.15 Years ↑ | 2.78 Years |
| Average Office Actions: | 1.76 ↑ | 1.69 |
Which Technology Area Amgen Inc. is filing most patents in? (Last 10 years)
| Art Unit | Definition | Total Applications |
| 1646 | Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology | 206 |
| 1624 | Organic Chemistry | 182 |
| 1644 | Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology | 159 |
| 1647 | Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology | 144 |
| 1626 | Organic Chemistry | 126 |
How many patents are Amgen Inc. filing every year?
| Year | Total Applications | Predicted |
| 2022 | 0* | 516 |
| 2021 | 56* | 538 |
| 2020 | 109 | 494 |
| 2019 | 89 | 89 |
| 2018 | 80 | – |
| 2017 | 67 | – |
| 2016 | 87 | – |
| 2015 | 78 | – |
| 2014 | 94 | – |
| 2013 | 70 | – |
*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published
Recently filed patent applications of Amgen Inc. in USPTO?
Application number: 17/642,345
Abstract:
–
Publication date: –
Applicant: Amgen Inc.
Inventors: Mehran Mojarrad
Publication number: None
Application number: 17/641,736
Abstract:
–
Publication date: –
Applicant: Amgen Inc.
Inventors: Ashish Sharma
Publication number: None
Application number: 17/638,395
Abstract:
–
Publication date: –
Applicant: Amgen Inc.
Inventors: B Boggara Mohan
How are Amgen Inc.’s applications performing in USPTO?
| Application Number | Title | Status | Art Unit | Examiner |
| 17/642,345 | Light-Activated Ultrasonic Delivery And Manipulation Of Liquid Medication From A Drug Reservoir | Docketed New Case – Ready for Examination | OPAP | Central, Docket |
| 17/641,736 | Purification Method For Bispecific Antigen-Binding Polypeptides With Enhanced Protein L Capture Dynamic Binding Capacity | Application Undergoing Preexam Processing | – | – |
| 17/638,395 | Systems And Methods For Prediction Of Protein Formulation Properties | Sent to Classification contractor | – | – |
| 17/637,520 | Activatable Injection Device For Drug Delivery | Sent to Classification contractor | – | – |
| 17/633,768 | Anti-Sclerostin Antibody Formulations | Application Undergoing Preexam Processing | – | – |
